These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 16449573)

  • 1. HIV prevention case management is not cost-effective.
    Cohen DA; Wu SY; Farley TA
    Am J Public Health; 2006 Mar; 96(3):400-1; author reply 401. PubMed ID: 16449573
    [No Abstract]   [Full Text] [Related]  

  • 2. Get Connected: an HIV prevention case management program for men and women leaving California prisons.
    Myers J; Zack B; Kramer K; Gardner M; Rucobo G; Costa-Taylor S
    Am J Public Health; 2005 Oct; 95(10):1682-4. PubMed ID: 16186447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of prevention referrals for high-risk HIV-negatives in San Francisco.
    Heumann KS; Marx R; Lawrence SJ; Stump DL; Carroll DP; Hirozawa AM; Katz MH; Kahn JG
    AIDS Care; 2001 Oct; 13(5):637-42. PubMed ID: 11571010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prisoners' knowledge of HIV/AIDS and its prevention in Kerman, Islamic Republic of Iran.
    Nakhaee FH
    East Mediterr Health J; 2002 Nov; 8(6):725-31. PubMed ID: 15568449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing the potential benefits of HIV post-exposure prophylaxis.
    Roland ME
    AIDS; 2006 Sep; 20(14):1889-90. PubMed ID: 16954731
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost of preventing HIV infection after sexual exposure.
    Lindbloom EJ; Stevermer JJ
    J Fam Pract; 1998 Oct; 47(4):251-2. PubMed ID: 9789505
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV prevention programs proven cost-effective.
    AIDS Alert; 1998 Sep; 13(9):107-8. PubMed ID: 11365792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of cost-effectiveness analysis in assessing HIV-prevention interventions.
    Kahn JG; Sanstad KC
    AIDS Public Policy J; 1997; 12(1):21-30. PubMed ID: 10915254
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-effectiveness of HIV screening in acute care settings.
    Owens DK; Nease RF; Harris RA
    Arch Intern Med; 1996 Feb; 156(4):394-404. PubMed ID: 8607724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Containing the spread of HIV infection among high-risk groups.
    Bean P
    Am Clin Lab; 2002 Jun; 21(5):19-21. PubMed ID: 12122779
    [No Abstract]   [Full Text] [Related]  

  • 11. [Knowledge, beliefs and attitudes of inmates towards AIDS and HIV infection: a survey in a Marseille penitentiary center].
    Delorme C; Rotily M; Escaffre N; Galinier-Pujol A; Loundou A; Moatti JP
    Rev Epidemiol Sante Publique; 1999 Jun; 47(3):229-38. PubMed ID: 10422117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preference for sex on amphetamine: a marker for HIV risk behaviour among male intravenous amphetamine users in Stockholm.
    Käll K; Nilsonne A
    AIDS Care; 1995; 7(2):171-88. PubMed ID: 7619871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in sexual risk behavior among participants in a PrEP HIV prevention trial.
    Guest G; Shattuck D; Johnson L; Akumatey B; Clarke EE; Chen PL; MacQueen KM
    Sex Transm Dis; 2008 Dec; 35(12):1002-8. PubMed ID: 19051397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a psychometric instrument designed to assess the HIV risk behaviors of ex-prisoners.
    Balogun JA; Abiona TC
    J Correct Health Care; 2010 Oct; 16(4):287-98. PubMed ID: 20881143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV risk behaviors, knowledge, and prevention education among offenders under community supervision: a hidden risk group.
    Belenko S; Langley S; Crimmins S; Chaple M
    AIDS Educ Prev; 2004 Aug; 16(4):367-85. PubMed ID: 15342338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Project: HIV prevention for incarcerated youth in Indiana.
    Schlapman N; Cass PS
    J Community Health Nurs; 2000; 17(3):151-8. PubMed ID: 10985009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Bayesian approach to net health benefits: an illustration and application to modeling HIV prevention.
    Johnson-Masotti AP; Laud PW; Hoffmann RG; Hayat MJ; Pinkerton SD
    Med Decis Making; 2004; 24(6):634-53. PubMed ID: 15534344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV prevention through case management for HIV-infected persons--selected sites, United States, 1989-1992.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1993 Jun; 42(23):448-9, 455-6. PubMed ID: 8502220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sexual risk taking].
    Sieber M
    Ther Umsch; 1994 Feb; 51(2):136-9. PubMed ID: 8128390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of screening for HIV.
    Taiwo BO
    N Engl J Med; 2005 May; 352(20):2137-9; author reply 2137-9. PubMed ID: 15901873
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.